DE602006020057D1 - A1-adenosinrezeptoragonisten - Google Patents

A1-adenosinrezeptoragonisten

Info

Publication number
DE602006020057D1
DE602006020057D1 DE602006020057T DE602006020057T DE602006020057D1 DE 602006020057 D1 DE602006020057 D1 DE 602006020057D1 DE 602006020057 T DE602006020057 T DE 602006020057T DE 602006020057 T DE602006020057 T DE 602006020057T DE 602006020057 D1 DE602006020057 D1 DE 602006020057D1
Authority
DE
Germany
Prior art keywords
adenosine receptor
receptor agonist
angina
release
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006020057T
Other languages
English (en)
Inventor
Elfatih Elzein
Xiaofen Li
Jeff Zablocki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Palo Alto Inc
Original Assignee
CV Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CV Therapeutics Inc filed Critical CV Therapeutics Inc
Publication of DE602006020057D1 publication Critical patent/DE602006020057D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE602006020057T 2005-10-13 2006-10-11 A1-adenosinrezeptoragonisten Active DE602006020057D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72661605P 2005-10-13 2005-10-13
PCT/US2006/039975 WO2007047401A2 (en) 2005-10-13 2006-10-11 A1 adenosine receptor agonists

Publications (1)

Publication Number Publication Date
DE602006020057D1 true DE602006020057D1 (de) 2011-03-24

Family

ID=37865975

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006020057T Active DE602006020057D1 (de) 2005-10-13 2006-10-11 A1-adenosinrezeptoragonisten

Country Status (8)

Country Link
US (2) US7488720B2 (de)
EP (1) EP1943251B8 (de)
JP (1) JP2009511593A (de)
AT (1) ATE497960T1 (de)
CA (1) CA2625783A1 (de)
DE (1) DE602006020057D1 (de)
ES (1) ES2358351T3 (de)
WO (1) WO2007047401A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE497960T1 (de) * 2005-10-13 2011-02-15 Cv Therapeutics Inc A1-adenosinrezeptoragonisten
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
BR112019022918A2 (pt) * 2017-05-19 2020-05-26 Alltech, Inc. Agentes farmacêuticos, composições e métodos relativos aos mesmos
WO2023241699A1 (zh) * 2022-06-17 2023-12-21 上海森辉医药有限公司 一种环戊基腺苷衍生物及其药物用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5364620A (en) 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US4902514A (en) 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
DE69932173T2 (de) 1998-10-16 2007-06-06 Pfizer Inc. Adeninderivate
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030078232A1 (en) 2001-08-08 2003-04-24 Elfatih Elzein Adenosine receptor A3 agonists
KR20050097971A (ko) 2003-02-03 2005-10-10 씨브이 쎄러퓨틱스, 인코포레이티드 Ａ₁아데노신 수용체의 부분 및 전 작용제
ATE497960T1 (de) * 2005-10-13 2011-02-15 Cv Therapeutics Inc A1-adenosinrezeptoragonisten

Also Published As

Publication number Publication date
WO2007047401A3 (en) 2007-06-14
US7488720B2 (en) 2009-02-10
EP1943251B8 (de) 2011-03-23
ES2358351T8 (es) 2011-06-15
ATE497960T1 (de) 2011-02-15
CA2625783A1 (en) 2007-04-26
JP2009511593A (ja) 2009-03-19
EP1943251B1 (de) 2011-02-09
US20070087994A1 (en) 2007-04-19
WO2007047401A2 (en) 2007-04-26
US20090137520A1 (en) 2009-05-28
EP1943251A2 (de) 2008-07-16
ES2358351T3 (es) 2011-05-09

Similar Documents

Publication Publication Date Title
Prudent et al. The mitochondria–endoplasmic reticulum contact sites: a signalling platform for cell death
TW200616649A (en) Partial and full agonists of A1 adenosine receptors
PE20121029A1 (es) Marcadores de riesgo para enfermedad cardiovascular
Kurose et al. Myofibroblasts and inflammatory cells as players of cardiac fibrosis
CL2011000978A1 (es) Compuestos derivados de fenil-amida o piridil-amida, agonistas de gpbar1; proceso de preparacion; composicion farmaceutica; y su uso en diabetes, isquemia, obesidad, dislipidemia, entre otras.
MY180473A (en) Imaging and evaluating embryos, oocytes, and stem cells
CL2009001476A1 (es) Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular.
CL2007002867A1 (es) Compuestos derivados de 2-(bencimidazolil)purina, inhibidores de janus quinasa 3; composicion farmaceutica que los contiene; y su uso para tratar enfermedades autoinmune, inflamatorias, cardiovasculares, rechazo de implante, entre otras.
DE602006020057D1 (de) A1-adenosinrezeptoragonisten
WO2007101225A3 (en) Methods to identify inhibitors of the unfolded protein response
NO20081212L (no) Xantinderivater som selektive HM74A agonister
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
BRPI0911273A2 (pt) inibidor de dpp-iv combinado com outro agente antidiabético, comprimidos que compreendem tais formulações, seu uso e processo para sua preparação
DE602006003628D1 (de) Purinderivate als a2a-rezeptoragonisten
GT200600179A (es) Proceso para preparar oxindoles y tio-oxindoles 3,3-disustituidos
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
Chimienti et al. Increased TFAM binding to mtDNA damage hot spots is associated with mtDNA loss in aged rat heart
DE602006019595D1 (de) Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors
PE20060558A1 (es) Conjugados para el diagnostico de enfermedades asociadas con angiogenesis que comprenden un ligante especifico para angiogenesis y una tintura de cianina
EA200701592A1 (ru) Композиты и способы их получения и использования
DE602006015686D1 (de) Als agonisten des gpr38-rezeptors geeignete biarylverbindungen
CL2009000793A1 (es) Variantes de estreptoquinasa que contienen cisteina y sus formas covalentemente modificadas; composicion farmaceutica que las comprende; y su uso para tratar una enfermedad o un trastorno tal como infarto del miocardio, trombosis vascular, embolia pulmonar, apoplejia, accidente vascular, angina, entre otras.
CL2007002427A1 (es) Compuestos derivados heterociclicos, inhibidores de metaloproteinasa de matriz; proceso de preparacion; composicion farmaceutica, util para el tratamiento o profilaxis de enfermedades inflamatorias o desordenes autoinmunes.
WO2008064304A3 (en) Compositions and methods for the identification of inhibitors of protein synthesis
WO2004069185A3 (en) Partial and full agonists of a1 adenosine receptors

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: GILEAD PALO ALTO, INC., FOSTER CITY, CALIF., US